Vindesine in the treatment of refractory hematologic malignancies: A phase II study
- 1 January 1982
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 6 (5) , 649-652
- https://doi.org/10.1016/0145-2126(82)90080-7
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomasCancer Chemotherapy and Pharmacology, 1979
- Vindesine a short review of preclinical and first clinical dataCancer Chemotherapy and Pharmacology, 1979
- PHASE-II CLINICAL-TRIAL WITH VINDESINE FOR REMISSION INDUCTION IN ACUTE-LEUKEMIA, BLASTIC CRISIS OF CHRONIC MYELOID-LEUKEMIA, LYMPHOSARCOMA, AND HODGKINS-DISEASE - ABSENCE OF CROSS-RESISTANCE WITH VINCRISTINE1978